Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.0%

3 terminated/withdrawn out of 43 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

7%

3 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed trials have results

Key Signals

11 recruiting1 with results

Enrollment Performance

Analytics

N/A
24(68.6%)
Phase 2
7(20.0%)
Phase 4
2(5.7%)
Phase 3
1(2.9%)
Phase 1
1(2.9%)
35Total
N/A(24)
Phase 2(7)
Phase 4(2)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (43)

Showing 20 of 43 trials
NCT04909125Not ApplicableActive Not Recruiting

Breast Fractionation Study - Standard Versus Investigational Fractionation Trial - Nodal Radiation

Role: lead

NCT02514512Not ApplicableActive Not Recruiting

Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking

Role: lead

NCT06432478Not ApplicableRecruiting

3D Printed Custom Applicators for HDR BT (DISCO)

Role: lead

NCT03073278Not ApplicableRecruiting

Focal Radiotherapy for Previously Treated Prostate Cancer Patients

Role: lead

NCT04649125Not ApplicableRecruiting

Advanced Techniques For Single-fraction Palliative Radiotherapy Versus Standard Multi Fraction Radiation

Role: lead

NCT01742403Not ApplicableActive Not Recruiting

Continuous Monitoring of Prostate Position During Radiotherapy

Role: lead

NCT06650033Not ApplicableRecruiting

Pelvis Adaptive Radiotherapy (ART)

Role: lead

NCT02967848Active Not Recruiting

Liver Function Investigation With SPECT

Role: lead

NCT04658537Not ApplicableActive Not Recruiting

Advanced Techniques for Single-fraction Palliative Radiotherapy Versus ASPIRE-single

Role: lead

NCT06547398Not ApplicableRecruiting

Prostate Adaptive Radiation Therapy

Role: lead

NCT03386045Not ApplicableActive Not Recruiting

Optimal Prostate Study

Role: lead

NCT04310891Active Not Recruiting

Markerless Image Guidance Using Intrafraction Kolovoltage X-ray Imaging for Lung Cancer Radiotherapy

Role: lead

NCT03505229Not ApplicableActive Not Recruiting

Span-C-SBRT for Pancreatic Cancer

Role: lead

NCT06546592Not ApplicableRecruiting

Locally Optimised Contouring With AI Technology for Radiotherapy

Role: lead

NCT05340582Phase 2Recruiting

Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infants

Role: collaborator

NCT06655207Not ApplicableRecruiting

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage

Role: collaborator

NCT06307015Not ApplicableRecruiting

De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)

Role: lead

NCT06180616Phase 2Not Yet Recruiting

Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity

Role: lead

NCT07052877Not Yet Recruiting

The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab

Role: lead

NCT06127654Phase 3Not Yet Recruiting

Ventilation Imaging to Improve the Quality of Life for Patients With Lung Cancer Treated With Radiation Therapy

Role: collaborator